CAPTRUST Financial Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Sell
36,695
-58
-0.2% -$828 ﹤0.01% 2288
2026
Q1
$617K Buy
36,753
+4,986
+16% +$89.2K ﹤0.01% 1896
2025
Q4
$509K Sell
31,767
-4,892
-13% -$72.8K ﹤0.01% 1890
2025
Q3
$453K Sell
36,659
-742
-2% -$8.7K ﹤0.01% 1883
2025
Q2
$431K Buy
37,401
+3,936
+12% +$46.7K ﹤0.01% 1827
2025
Q1
$502K Sell
33,465
-22,062
-40% -$369K ﹤0.01% 1638
2024
Q4
$961K Buy
55,527
+1,728
+3% +$33.3K ﹤0.01% 1256
2024
Q3
$997K Buy
+53,799
New +$1.08M ﹤0.01% 1190
2024
Q1
Sell
-12,319
Closed -$218K 2249
2023
Q4
$218K Sell
12,319
-3,336
-21% -$67.2K ﹤0.01% 2337
2023
Q3
$376K Buy
+15,655
New +$384K ﹤0.01% 1839
2022
Q3
Sell
-1,885
Closed -$37K 2415
2022
Q2
$37K Sell
1,885
-18
-0.9% -$478 ﹤0.01% 2979
2022
Q1
$60K Buy
1,903
+1,237
+186% +$34.7K ﹤0.01% 2660
2021
Q4
$15K Buy
666
+34
+5% +$887 ﹤0.01% 3472
2021
Q3
$18K Buy
632
+64
+11% +$1.95K ﹤0.01% 3220
2021
Q2
$22K Buy
568
+1
+0.2% +$36 ﹤0.01% 3028
2021
Q1
$16K Buy
567
+482
+567% +$16.5K ﹤0.01% 3137
2020
Q4
$2K Sell
85
-122
-59% -$2.49K ﹤0.01% 3092
2020
Q3
$3K Buy
207
+40
+24% +$839 ﹤0.01% 2640
2020
Q2
$3K Buy
+167
New +$2.99K ﹤0.01% 2497
2019
Q4
Sell
-1,989
Closed -$93K 1147
2019
Q3
$93K Buy
1,989
+358
+22% +$16.6K ﹤0.01% 801
2019
Q2
$85K Buy
1,631
+25
+2% +$1.47K ﹤0.01% 804
2019
Q1
$111K Sell
1,606
-250
-13% -$16.8K ﹤0.01% 661
2018
Q4
$111K Buy
1,856
+314
+20% +$27.1K 0.01% 555
2018
Q3
$179K Sell
1,542
-11
-0.7% -$1.24K 0.01% 466
2018
Q2
$196K Buy
1,553
+218
+16% +$26.5K 0.01% 367
2018
Q1
$142K Buy
1,335
+62
+5% +$6.86K 0.01% 372
2017
Q4
$139K Buy
+1,273
New +$127K 0.01% 381

Other funds holding CLB

CAPTRUST Financial Advisors's CLB Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Core Laboratories (CLB) stake by 0.16% in Q2 2026, selling an estimated $828 and leaving 36,695 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

CAPTRUST Financial Advisors first reported a position in CLB in Q4 2017 and has held it in 27 quarters since. The position peaked at $997K in Q3 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • CAPTRUST Financial Advisors held 36,695 shares of Core Laboratories worth $427K as of Q2 2026.
  • CAPTRUST Financial Advisors sold 58 Core Laboratories shares in Q2 2026, an estimated $828.
  • Core Laboratories made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2288 holding.
  • CAPTRUST Financial Advisors first reported a position in Core Laboratories in Q4 2017 and has held it in 27 quarters since.
  • CAPTRUST Financial Advisors's Core Laboratories position peaked at $997K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.